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PI3K/AKT signaling determines a dynamic switch
between distinct KSRP functions favoring skeletal
myogenesis
P Briata*,1, W-J Lin2, M Giovarelli3,4, M Pasero3,4, C-F Chou2, M Trabucchi5,6, MG Rosenfeld5, C-Y Chen2 and R Gherzi*,1
Skeletal myogenesis is orchestrated by distinct regulatory signaling pathways, including PI3K/AKT, that ultimately control
muscle gene expression. Recently discovered myogenic micro-RNAs (miRNAs) are deeply implicated in muscle biology.
Processing of miRNAs from their primary transcripts is emerging as a major step in the control of miRNA levels and might be well
suited to be regulated by extracellular signals. Here we report that the RNA binding protein KSRP is required for the correct
processing of primary myogenic miRNAs upon PI3K/AKT activation in myoblasts C2C12 and in the course of injury-induced
muscle regeneration, as revealed by Ksrp knock-out mice analysis. PI3K/AKT activation regulates in opposite ways two distinct
KSRP functions inhibiting its ability to promote decay of myogenin mRNA and activating its ability to favor maturation of
myogenic miRNAs. This dynamic regulatory switch eventually contributes to the activation of the myogenic program.
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Myogenic differentiation is the end point of a cascade of
events that remove myoblasts from the cell cycle and
ultimately determine the characteristic pattern of skeletal
muscle gene expression and the formation of multinucleated
myotubes.1 Once differentiated, adult muscles retain the
capacity to regenerate in response to exercise or injury by
activation and proliferation of satellite cells.2,3 Skeletal
myogenesis is orchestrated by distinct regulatory signaling
pathways, including phosphatidylinositol-3-kinase (PI3K)/
AKT, that ultimately change tissue-specific gene expression
programs during muscle cell differentiation and tissue
reconstruction after trauma.4 In the recent few years,
extensive analysis of the composition of the transcriptome
assembled on the chromatin of myogenic loci has been
performed (reviewed in Guasconi and Puri5), although knowl-
edge on the mechanisms that post-transcriptionally regulate
muscle differentiation and regeneration is more limited.6–9
Recently, genetic, and biological evidence of an essential
role of microRNAs (miRNAs) in muscle development and
function has been accumulating and a group of miRNAs,
highly enriched in skeletal muscle (referred to as myomiRs),
has been identified (reviewed in Williams et al.,10 and Gu¨ller
and Russell11). MyomiRs influencemultiple aspects of muscle
development and function through their regulation of key
genes controlling myogenesis.12–14 Deregulated expression
of some myomiRs results in pathological conditions.15–17
miRNA encoding genes are transcribed as primary miRNA
transcripts (pri-miRNAs) by RNA polymerase II. The mechan-
ism by which pri-miRNAs are processed first to stem-loop
structured miRNA precursors (pre-miRNAs) and then to
mature miRNAs involves two sequential endonucleolytic
cleavages operated by multiprotein complexes including the
RNase III enzymes Drosha, in the nucleus, and Dicer, in
the cytoplasm (reviewed in Krol et al.18). Mature miRNAs, in
the context of the RNA-induced silencing complex (RISC), are
able to silence gene expression by binding to partially
complementary target sites predominantly located in the 30
untranslated region (30UTR) of target messenger RNAs
(mRNAs).18 This results either in the repression of translation
or in the deadenylation and destabilization of the target mRNA
(reviewed in Fabian et al.19).
In the last few years, the relevance of post-transcriptional
control of miRNA biogenesis has been discovered (see
Newman and Hammond20 for a recent review) and, notably,
miRNA processing defects result in pathological conditions
including cancer.21,22 Inactivation of Dicer in muscles results
in perinatal lethality due to skeletal muscle hypoplasia, thus
highlighting the essential role of the miRNA processing
machinery in muscle homeostasis.23 Recently, Paroo
et al.,24 reported that MAPK Erk phosphorylates TRBP, a
protein factor belonging to the core Dicer complex, and affects
miRNAmaturation. This observation points to the relevance of
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post-translational modifications of factors involved in miRNA
biogenesis in the modulation of miRNA expression and
function. However, regulation of a general molecular machine,
such as the Dicer complex, does not explain how different
signaling pathways can regulate maturation of different
subsets of miRNAs in specialized cellular environments.
It has been recently shown that different regulatory
proteins, acting as either activators or repressors of Drosha
and Dicer machineries, influence the processing of select
miRNAs (reviewed in Trabucchi et al.25). Among them, the
single-strand RNA binding protein KSRP (reviewed in Briata
et al.26) interacts with the terminal loop of select miRNA
precursors and promotes their maturation in cultured cells.27–29
Importantly, KSRP has been shown to regulate gene
expression also promoting the decay of inherently labile
mRNAs in several cellular contexts including C2C12 myo-
blasts.26 KSRP distinct functions are regulated by different
protein kinases, including MAPK p38, PI3K/AKT and
ATM.8,29,30 An unresolved issue is whether a specific
signaling pathway regulates only a single KSRP function
(i.e. affecting either mRNA decay or miRNA maturation) or is
able to induce a dynamic change between KSRP functions in
order to produce relevant phenotypes in a specific cellular
context.
Here, we report that activation of the PI3K/AKT signaling is
responsible for myomiR maturation during C2C12 myoblasts
differentiation with KSRP being required for this function.
Importantly, myomiR maturation in the course of injury-
induced muscle regeneration is impaired in Ksrp knock-out
mice. PI3K/AKT signaling activation that occurs during
myogenesis determines a switch between two distinct KSRP
functions, inhibiting its ability to promote the decay of
myogenin mRNAwhile activating its ability to favor maturation
of myogenic miRNAs.
Results
PI3K/AKT signaling induces myomiR maturation in
C2C12 myoblasts. In order to assess the contribution of
the PI3K/AKT signaling pathway to myomiR induction during
differentiation of C2C12 myoblasts, we continuously exposed
cells to PI3K inhibitor LY294002 (LY) throughout the
transition from myoblasts to myotubes induced by
differentiation medium (DM). LY was able to impair DM-
induced expression of myogenic differentiation markers
(Supplementary Figure S1a, and Serra et al.31) and to
strongly inhibit the expression of miR-1a, miR-133b and miR-
206 (members of the myomiR family10,11) induced by DM
(Figure 1a). Importantly, the comparative analysis of primary
and mature miRNAs revealed that LY specifically impairs
myomiR maturation (Figures 1a and b). AKT kinases are the
major downsteam effectors of PI3K.32 As the relative
contribution of the two AKT isoforms expressed in C2C12
cells (Akt1 and Akt2) to differentiation is still debated,33 we
downregulated either isoform before exposure to DM
(Supplementary Figure S1b) and obtained inhibition of the
expression of myogenic differentiation markers
(Supplementary Figure S1c, and Serra et al.31). Silencing
experiments demonstrated that both Akt1 and Akt2 are
required for DM-induced maturation of miR-1a, miR-133b
and miR-206 (compare the expression of mature and primary
miRNA in Figures 1c and d). In agreement with a role of AKT
in myomiR maturation, expression of a membrane-bound
myristoilated and constitutively active form of Akt2 (myr-
AKT230) strongly enhanced the expression of myomiRs in
C2C12 cells cultured in DM without affecting the expression
of the corresponding pri-miRNAs (Figures 1e and f).
PI3K/AKT could cross talk with other signaling pathways
activated during DM-induced myoblast differentiation and this
could influence myomiR maturation. In order to minimize this
potential interference, we activated PI3K/AKT signaling in
exponentially growing cells (cultured in growth medium, GM).
Indeed, the expression ofmyr-AKT2 in C2C12 cells cultured in
GM (myr-AKT2/GM)-induced the expression of differentiation
markers (Supplementary Figure S2a). To obtain a compre-
hensive picture of the miRNome changes induced by
myr-AKT2/GM in C2C12 myoblasts, we performed miRNA
microarray analysis and found 37 miRNAs significantly
regulated (Figure 2a). As our aim was to investigate the
contribution of PI3K/AKT activation in the context of physio-
logical C2C12 myoblast differentiation, we focused exclu-
sively on miRNAs whose expression was similarly affected by
myr-AKT2/GM and by DM (Figure 2a and Supplementary
Figure S2b). miRNA array results were validated (by both
quantitative RT-PCR (qPCR) analysis and RNase protection
assays), with the exception of miR-21, whose expression was
not affected bymyr-AKT2/GM (Figures 2b and c). Importantly,
AKT activation enhanced miRNA expression inducing their
maturation without significantly affecting the corresponding
primary miRNA levels with the only exception of miR-351
whose primary transcript levels were significantly upregulated
(Figure 2b).
Insulin and IGF-I are known as physiological activators of
PI3K/AKT signaling in different cell types, including C2C12
myoblasts.34 Treatment of serum-starved C2C12 cells with
insulin (106 M) was able to induce muscle differentiation
markers (Supplementary Figure 2c) and to enhance the
expression of mature miR-1a, 133b, 206, 378, and 532-5p
without increasing the levels of their primary transcripts
(Figure 2d and Supplementary Figure 2d).
Connexin 43 is one of the few validated targets of miR-1a
and miR-20613,35 and, consistent with the increased expres-
sion of thesemyomiRs, we observed a similar downregulation
of connexin 43 protein levels in C2C12 myoblasts upon either
PI3K/AKT signaling activation or culture in DM (Figure 2e).
Altogether these data demonstrate that either physiological
or forced activation of PI3K/AKT signaling in C2C12 myo-
blasts induces the expression of a group of myogenic miRNAs
activating their maturation.
KSRP is required for AKT-induced myomiR maturation.
We reported that KSRP is a target of PI3K/AKT signaling in
different cell lines, and that phosphorylation by AKT1 and 2
causes an impairment of its decay-promoting function on a
variety of inherently labile mRNAs.26 We investigated
whether KSRP function is required for PI3K/AKT-induced
maturation of myomiRs in C2C12 myoblasts and whether
KSRP phosphorylation by AKT affects its ability to promote
miRNA precursor maturation.
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We transiently downregulated KSRP in myr-AKT2/GM
C2C12myoblasts (Supplementary Figure S3a). KSRP knock-
down impaired the myr-AKT2-dependent induction of differ-
entiation markers (Supplementary Figure S3b) and the
maturation of myogenic miRNAs (Figure 3a). We obtained
similar results analyzing C2C12 transfectants in which the
expression of KSRP was stably downregulated by shRNA
(Supplementary Figure S3c).
Using a primary miRNA in vitro processing assay27 we
showed that extracts from both myr-AKT2/GM- and
DM-cultured C2C12 myoblasts were able to process
pri-miR-206 into pre-miR-206 in vitro, whereas extracts from
C2C12 myoblasts cultured in GM were not (left panels in
Supplementary Figures S3d and e). In order to investigate the
possibility that phosphorylation by AKT directly affects the
ability of KSRP to process pri-myomiRs to pre-myomiRs
in vitro, either unphosphorylated or AKT2-phosphorylated,
recombinant KSRP30 was added to extracts from C2C12
myoblasts cultured in GM. Unphosphorylated KSRP was
unable to promote pri-miR-206 and pri-miR-1a-2 processing
*** *** ***
GM DM DM+LY
qPCR
GM DM DM+LY
qPCR
miR-1a
U6
miR-133
let7-a
U6
miR-206
***
***
siControl+GM siControl+DM
siAkt1+DM siAkt2+DM
*** ***
******
qPCR
Northern Blot
qPCR
GM 1d DM 1d DM+myr-Akt2
qPCR
siControl+GM siControl+DM
siAkt1+DM siAkt2+DM
Figure 1 PI3K/AKT signaling controls maturation of myogenic miRNAs in differentiating C2C12 myoblasts. (a and b) Quantitative RT-PCR (qPCR) analysis of miR-1a,
miR-133b, miR-206 (a), and their respective primary transcripts (b) in C2C12 cells cultured either in growth medium (GM) or differentiation medium (DM) for 2 days in the
presence of either DMSO (the solvent of LY294002 (LY), labeled as DM), or LY (25 mM, labeled as DMþ LY). The values shown are averages (±S.E.M.) of three
independent experiments performed in triplicate. (c and d) qPCR analysis of miR-1a, miR-133b, miR-206 (c), and their respective primary transcripts (d) in C2C12 cells
transfected with siControl, siAkt1, or siAkt2 (40 nM), and cultured either in GM or in DM for 2 days. The values shown are averages (±S.E.M.) of three independent
experiments performed in triplicate. (e) Northern blot analysis of total RNA purified from C2C12 myoblasts cultured either in GM or DM (1 day) and then infected with either a
control empty adenoviral vector (1d DM) or an adenoviral vector expressing constitutively active myristoylated AKT2 (1d DMþmyr-AKT2) for further 2 days. Representative
blots sequentially hybridized with miR-133, miR-1a, and U6 probes (left panels) or with miR-206, let-7a, and U6 probes (right panels) are displayed. (f) qPCR analysis of
pri-miR-1a-2, pri-miR-133b, and pri-miR-206 in the RNA samples from C2C12 cells treated as in panel e. Statistical significance: ***Po0.001 (Student’s t-test)
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Figure 2 Identification and validation of miRNAs whose expression is induced by PI3K/AKT signaling in C2C12 myoblasts cultured in GM. (a) C2C12 myoblasts
cultured in GM were infected with either a control empty adenoviral vector (GM no.;1.0, 2.0, and 3.0 represent three distinct experiments) or an adenoviral vector
expressing myr-AKT2 (A2no.;1.0, 2.0, and 3.0 represent three distinct experiments) and harvested after 2 days. Total RNA was extracted and analyzed by miRNA microarrays.
Green or red color on the heat map indicates a decrease or increase of miRNA levels, respectively, and color intensities correspond to relative signal levels on a logarithmic
scale. The green arrow points to miR-21, whose expression was significantly reduced also by a 2-day treatment of C2C12 myoblasts with DM. The red arrow and the
red brackets indicate miRNAs whose expression was significantly enhanced also by a 2-day treatment of C2C12 myoblasts with DM. Statistical analysis was performed
using Student’s t-test. (b) qPCR analysis of miRNAs and their respective primary transcripts (as indicated) in C2C12 myoblasts cultured in GM and infected with either a
control or a myr-AKT2-expressing adenoviral vector. The values shown are averages (±S.E.M.) of three independent experiments performed in triplicate. (c) RNase
protection assay performed on the same RNA samples displayed in panel b. Samples were analyzed for the expression of either miR-206 or miR-16 (as control).
Lanes corresponding to assays performed in the absence of RNA (no RNA) or in the presence of only RNA probes without digestion (probe) are also displayed. (d) qPCR
analysis of miRNAs and their respective primary transcripts (as indicated) in C2C12 myoblasts serum-starved for 16 h and cultured for two additional hours in the same
medium in the absence or in the presence of 106 M insulin. The values shown are averages (±S.E.M.) of three independent experiments performed in triplicate.
(e) Immunoblot analysis of total cell extracts from C2C12 cells cultured either in GM (and infected with control or myr-AKT2 vectors) or in DM (for 2 or 3 days). Blots were
sequentially hybridized with anti-connexin 43 and anti-alpha-tubulin antibodies and films subjected to densitometric scanning. Densitometric values (%) of connexin
43 expression after normalization for alpha-tubulin expression are presented. Representative blots are displayed. Statistical significance: **Po0.01 and ***Po0.001
(Student’s t-test)
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while in vitro phosphorylation by AKT2 activated the proces-
sing function of KSRP (Figure 3b and data not shown). S193A
mutation, which abrogates AKT phosphorylation, impairs the
ability of AKT2 to activate the pri-miR-206 processing activity
of GST-KH1-4 (a protein that includes the four KH domains of
KSRP, comprises the AKT phosphorylation site,30 and
recapitulates KSRP activity to favor pri-miRNA processing)
(Supplementary Figure S4).
These results suggest the existence of a PI3K/AKT4KSRP
pathway that activates maturation of myomiRs in C2C12
myoblasts.
KSRP knockout impairs myomiR maturation in the
course of muscle regeneration. We have recently
generated Ksrp knock-out (Ksrp/, Supplementary Figure
S5a and b) mice that have been described elsewhere.36
Adult skeletal muscle regenerates in response to injuries
with a process in which PI3K/AKT signaling activation has
an essential role (reviewed in Schiaffino and Mammucari37
and Supplementary Figure S1a). As the regenerative
process has been recently linked to induction of myomiR
expression38 we asked whether Ksrp knockout affects
miomyR processing in injury-dependent muscle
regeneration.
In order to evaluate the expression of myomiRs during
muscle regeneration, both Ksrp/ and their wild-type (WT)
littermates were injected with cardiotoxin in the tibialis
anterioris muscle and sacrificed at different times (Supple-
mentary Figures S5c). The analysis of proliferation/differen-
tiation markers in regenerating muscles revealed a stronger
and more sustained induction of Ccna2 (also known as
Cyclin A2) in Ksrp/ in comparison with WT mice (Supple-
mentary Figures S5d). Conversely, myogenin induction at day
4 after injury was significantly impaired in Ksrp/ in
comparison with WT mice (Supplementary Figure S5e).
Hematoxylin–eosin staining of cross-sections of non-injured
(day 0) and injured muscles showed dishomogeneous and
hypernucleated regenerating myofibers at day 7 after cardi-
otoxin injection in Ksrp/ mice (Supplementary Figure S5f).
As shown in Supplementary Figure S5g and in the left panel
of Figure 4a, miR-206 expression transiently declined at day 2
post-injection in both WT and Ksrp/ mice and strongly
increased starting from day 4 to day 14 in WT animals. miR-
206 increase was significantly reduced in Ksrp/ mice when
compared with WT animals (Figure 4a, left panel). miR-133b
and miR-1a expression levels sharply decreased between
days 2 and 7 while almost reached pre-injection levels at day
14 (Figure 4a, middle and right panels). A significant reduction
of the expression of miR-133b and miR-1a was detectable at
day 14 in Ksrp/ mice when compared with WT (Figure 4a,
middle and right panels). Importantly, pri-miR-206 and
pri-miR-133b induction, occurring at day 4 post-injury, was
significantly higher in Ksrp/ than in WT mice suggesting
an accumulation of unprocessed primary myomiRs
(Figure 4b, left and middle panels). Also pri-miR-1a-2 levels,
although with a different kinetic compared with pri-miR-206
and pri-miR-133b, were significantly higher at day 4 in Ksrp/
mice when compared with WT animals (Figure 4b, right
panel).
Altogether, these data indicate that the induction of
myomiRs occurring during muscle regeneration is impaired
in Ksrp/ mice due to maturation blockade.
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Figure 3 KSRP is required for AKT-induced myomiR maturation and phosphorylation by AKT activated KSRP ability to process pri-miR-206. (a) qPCR analysis of miRNAs
(upper) and their respective primary transcripts (lower) in C2C12 myoblasts cultured in GM, transfected with either siControl or siKsrp, and infected with either a control
(Ad-Control) or a myr-AKT2-expressing adenoviral vector. The values shown are averages (±S.E.M.) of three independent experiments performed in triplicate. (b) In vitro pri-
miR-206 processing assays performed using total extracts from either C2C12 myoblasts cultured in GM pre-incubated with BSA (lanes 1–4), KSRP (30 nM, lanes 5–8), AKT2-
phosphorylated KSRP (30 nM, lanes 9–12), respectively. Internally 32P-labeled, pri-miR-206 RNA substrate was added and its processing monitored as described by
Briata et al.8 Statistical significance: **Po0.01 (Student’s t-test)
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PI3K/AKT inhibits KSRP ability to promote decay of myo-
genin mRNA while promotes its recruitment to myogenic
miRNA processing complexes. We and others have
shown that stabilization of inherently labile muscle specific
transcripts takes place during C2C12 cell differentiation.6–8
Myogenin and p21 mRNAs are unstable in C2C12 myoblasts
cultured in GM and KSRP is required for their decay
while MAPK p38-induced inactivation of KSRP (which
occurs in differentiating myoblasts) contributes to myogenin
and p21 induction.8 Figure 5a and Supplementary Figure
S6a show that AKT increased the half life of myogenin
and p21 mRNAs when activated in C2C12 myoblasts
cultured in GM. On the basis of this observation and
the above data, we hypothesized that PI3K/AKT signal-
ing activation reduces KSRP ability to promote mRNA
decay while induces its ability to promote miRNA
precursor maturation in the course of C2C12 myoblasts
differentiation.
To address this hypothesis, we first performed in vitro
mRNA degradation assays supplementing extracts from
C2C12 myoblasts cultured in DM with purified recombinant
KSRP.8 In vitro phosphorylation by AKT2 impairs the decay-
promoting activity of KSRP on a myogenin mRNA substrate
(Figure 5b), thus indicating that, besides inducing a sub-
cellular re-distribution of KSRP (Supplementary Figure S6b,
and Briata et al.26), phosphorylation by AKT2 directly affects
KSRP function on myogenin mRNA decay.
This finding, together with the observation that phosphor-
ylation by AKT2 enhances the ability of KSRP to promote
pri-miR-206 processing (Figure 3b) prompted us to address
the possibility that PI3K/AKT activation in C2C12 myoblasts
displaces KSRP from myogenic mRNA destabilizing com-
plexes and relocates it to primary myomiR processing
complexes. Indeed, ribonucleoprotein immunoprecipitation
(RIP) assays show that PI3K/AKT activation in C2C12 cells,
as well as culture in DM, caused dissociation of KSRP from
myogenin mRNA while it increased KSRP interaction with pri-
miR-133b, pri-miR-206, and pri-miR-532-5p (Figures 5c and d
and data not shown). Finally, we investigated whether PI3K/
AKT activation affects KSRP ability to interact with the
enzymatic complexes responsible for either labile mRNA
decay or pri-miRNA processing. Indeed, once phosphorylated
by AKT2, KSRP was unable to interact with the exosome
complex (represented by EXOSC10 component, Figure 5e)
while became capable to interact with the Drosha complex
(Figure 5f). As a control for AKT2-dependent inhibition of
KSRP interaction with the Exosome, we showed that the
exosome-binding ability of a recombinant KSRP mutated in
the critical Ser19330 was unaffected by AKT2 phosphorylation
(Figure 5e).
Altogether these data suggest that phosphorylation by
AKT displaces KSRP from myogenic mRNA-destabilizing
complexes, relocating it to primary myomiR-processing
complexes.
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Figure 4 Impaired maturation of myomiRs during muscle regeneration in Ksrp knock-out mice. (a and b) qPCR analysis of miRNAs (a) and their respective primary
transcripts (b) in total RNA samples extracted from tibialis anterioris muscles of either wild-type (Ksrpþ /þ ) or Ksrp/ mice before and at different intervals of time after
injection of cardiotoxin as indicated. The values shown are averages (±S.D.) of five independent animals for each experimental group. Assays were performed in triplicate.
Statistical significance: *Po0.05, **Po0.01, and ***Po0.001 (Student’s t-test)
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Discussion
In this manuscript we report that PI3K/AKT signaling activa-
tion occurring at early phases of C2C12 myoblast differentia-
tion induces the expression of myomiRs activating their
processing from primary transcripts with KSRP having a
required role in this pathway. AKT regulates in opposite ways
two distinct KSRP functions inhibiting its ability to promote
decay of myogenin mRNA and activating its ability to favor
maturation of myomiRs from precursors. This dynamic
regulatory switch eventually contributes to the activation of
the myogenic program.
PI3K/AKT signaling has been reported to regulate the
expression of somemiRNAs in fibroblast and epithelial cells39
while a role for the pathway in controlling miRNA maturation
has been only postulated.40 Our data indicate that either
physiological or forced activation of PI3K/AKT favors the
processing of primary myomiRs leading to accumulation of
their mature forms. We and Others have shown that KSRP
promotes processing of a select group of miRNAs, including
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Figure 5 AKT signaling activation inhibits KSRP ability to participate in a Myogenin mRNA decay complex while favors its association with a primary myomiR processing
complex. (a) qPCR analysis of myogenin and p21 (also known as Cdkn1a) expression in C2C12 myoblasts cultured in GM and infected with either a control (GM) or a
myr-AKT2-expressing adenoviral vector. Total RNA was isolated at the indicated times after the addition of DRB. The values shown are averages (±S.E.M.) of three
independent experiments performed in triplicate. (b) In vitro RNA degradation assays using S100 extracts from C2C12 myoblasts cultured in DM pre-incubated with BSA
(lanes 1–4), KSRP (30 nM, lanes 5–8), AKT2-phosphorylated KSRP (30 nM, lanes 9–12), respectively. Internally 32P-labeled and capped RNA substrates were added and
their decay monitored as described under Material and Methods. E3 is a stable unrelated transcript.9 Representative gels are displayed. (c) C2C12 myoblasts were cultured in
GM and infected with either control (GM) or myr-AKT2-expressing adenoviral vector. After 2 days cells were lysed, and total cell extracts were immunoprecipitated as
indicated. RNA was purified from immunocomplexes and analyzed by qPCR to detect Myogenin mRNA. The values shown are averages (±S.E.M.) of three independent
experiments performed in triplicate. (d) C2C12 myoblasts were cultured in GM and infected with either control (GM) or myr-AKT2-expressing adenoviral vector. After 2 days
cells were lysed, and total cell extracts were immunoprecipitated as indicated. RNA was purified from immunocomplexes and analyzed by qPCR to detect primary myomiRs as
indicated. The values shown are averages (±S.E.M.) of three independent experiments performed in triplicate. (e and f) GST pull-down of endogenous Exosc10 (e) and
Drosha (f) present in total extracts from C2C12 cells cultured in GM using the following proteins: GST, GST-KH1-4, GST-KH1-4 in vitro phosphorylated by AKT2, GST-KH1-
4(S193A), or GST-KH1-4(S193A) in vitro phosphorylated by AKT2 as indicated. GST-KH1-4(S193A) is mutated in Ser 193 in order to abolish the AKT phosphorylation site as
described by Gherzi et al.30 Proteins were analyzed by immunoblotting using the indicated antibodies. Representative blots are displayed. Statistical significance:
***Po0.001 (Student’s t-test)
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the let-7 family, in HeLa and other cell lines.27,29,41 KSRP
silencing in C2C12 myoblasts downregulates the expression
of the above miRNAs (Supplementary Figure S6c), thus
indicating that an overlap between miRNAs, whose expres-
sion is affected by KSRP knockdown in HeLa and C2C12
cells, does exist. However, the overlap is partial as some
KSRP-regulated miRNAs expressed in C2C12 myoblasts are
not expressed in HeLa cells (miR-1a, miR-133a, miR-133b,
miR-206, and miR-378) and, conversely, other KSRP-
regulated miRNAs are expressed in HeLa cells but not in
C2C12 myoblasts (miR-335 and miR-595) (according to
miRNA microarray analyses performed in this study and in
Trabucchi et al.27). KSRP interacts in C2C12 myoblasts with
myogenic (Figure 5d), as well as with non-myogenic pri-
miRNAs (Supplementary Figure S6d). However, PI3K/AKT
activation in C2C12 cells strongly enhances KSRP interaction
with myogenic pri-miRNAs (Figure 5d), as well as their
processing into miRNAs (Figure 2b) while it does not increase
either KSRP interaction with non-myogenic pri-miRNA or the
expression of the corresponding miRNAs (Supplementary
Figure S6d, e, and Figure 2b). It is also noteworthy that
maturation of primary let-7a-1 is constitutive in C2C12
myoblasts and is not affected by either DM or myr-AKT2/
GM (right panels in Supplementary Figures S3d and e). On
the basis of these data, we are tempted to hypothesize that
phosphorylation by AKT might increase the ability of KSRP to
interact with ribonucleoprotein complexes specifically com-
prising myomiR precursors. This could be achieved through
the interaction of AKT-phosphorylated KSRP with a specific
co-activator of myogenic pri-miRNA processing.
Studies performed in cultured myoblasts and in animals
have demonstrated that myomiRs regulate fundamental
aspects of myoblast biology such as differentiation and
proliferation.10,11 However, the molecular mechanisms by
which the expression of myomiRs is dynamically regulated by
activation of distinct signaling pathways during skeletal
myogenesis have not been elucidated. Our data highlight
the relevance of PI3K/AKT signaling as an exquisite regulator
of myomiR maturation. Noticeably, culture in DM, differently
from activation of AKT signaling in GM, strongly induces pri-
miR-133b and pri-miR-206 expression and moderately
enhances pri-miR1a-2 levels (Figure 1b). PI3K/AKT pathway
inhibition in C2C12 myoblasts cultured in DM does not reduce
the expression of primary myomiRs (Figures 1b and d) while
strongly impairs their maturation (Figures 1a and c). This is in
agreement with previous data from different laboratories
demonstrating the transcriptional regulation of primary myo-
miR levels upon myoblast exposure to DM (reviewed in
Williams et al.10). Altogether, these observations and our
findings suggest that a stringent control of myomiR expres-
sion occurs during myogenesis at different regulatory levels,
with PI3K/AKT signaling being central in the control of
maturation.
As other single-strand RNA binding proteins, KSRP proved
to be involved at different levels in RNA metabolism with its
ability to promote labile mRNA decay, as well as miRNA
precursor maturation as the most extensively studied func-
tions.26 However, despite the evidence that KSRP is targeted
by distinct signaling pathways,8,29,30 the possibility that a
specific signal induces a biological effect by regulating both
KSRP main functions in an integrated and dynamic way has
never been addressed. C2C12 myoblasts, an established
culture model of muscle satellite cells that we have previously
utilized to demonstrate KSRP function on labile myogenic
mRNA decay,8 were ideal to investigate this possibility.
Indeed, phosphorylation by AKT inhibits KSRP ability to
interact with the Exosome complex and to promote decay of
Myogenin mRNA while activates KSRP ability to interact with
Drosha complex and to favor the processing of myogenic
miRNAs.
Although studies on cultured muscle cells allowed us to
identify the PI3K/AKT4KSRP4myomiR processing path-
way, we obtained definitive evidence of the physiological
relevance of KSRP in primary myomiR processing using the
Ksrp knock-out mice that display an impaired myomiR
maturation during injury-induced muscle regeneration. How-
ever, the effect of Ksrp knockout onmyoblast proliferation and
differentiation markers, as well as on myofibers morphology is
transient. One possible explanation is that besides PI3K/AKT
signaling, other pathways are activated during the course of
muscle regeneration.5 These pathways, targeting effector
proteins different from KSRP, can modulate the molecular
events implicated in muscle regeneration in a KSRP-
independent way and, in principle, compensate for the
molecular defects due to KSRP ablation. Another possibility
is that Ksrp gene deletion leads to the overexpression of RNA
binding proteins (some have been previously described as
post-transcriptional targets of KSRP (reviewed in Briata
et al.26)) that could be able to compensate for some of the
KSRP functions in mice lacking Ksrp. Further studies will be
required to investigate the consequences of KSRP deletion
and the reduced myomiR expression on the function of
regenerated muscles.
PI3K/AKT signaling affects myogenesis at different levels,
regulating chromatin remodeling at myogenic loci and con-
trolling Cyclin D1 expression at post-transcriptional level.5,9
Our present data reveal an unanticipated additional effect
elicited by PI3K/AKT signaling, which dynamically integrates
two KSRP functions contributing to the post-transcriptional
control of skeletal myogenesis.
Materials and Methods
Cell cultures, transfections, plasmids and adenoviral infections.
Murine C2C12 myoblasts (obtained from ATCC, no. CRL-1772, Lot no. 58236521)
were cultured in DMEM plus 20% FBS (Growth Medium, GM). Myogenic
differentiation was induced by incubation in DMEM plus 2% horse serum
(Differentiation Medium, DM). For transient transfections, C2C12 cells were
electroporated using the Nucleofector II, according to manufacturer’s instructions
(Amaxa, Walkersville, MD, USA). C2C12 cell transfections aimed to obtain stable
shKSRP transfectants were performed using Lipofectamine Plus (Invitrogen,
Carlsbad, CA, USA) and Puromycin (Invivogen, San Diego, CA, USA) was used at
2.5mg/ml for selection. Pools of transfected cells were used for experiments. The
adenoviral vectors pAdCMVnull (Ad-Control) and pAdmyrAKT2 (myr-AKT2) were
purchased from Vector Biolabs (Eagleville, PA, USA) and used as previously
described.8
Recombinant proteins and antibodies. Production and purification of
recombinant GST-KH1-4 (comprising the four KH domain of human KSRP) were
performed as previously described.8 Baculovirus-based production and purification
of His-tagged human KSRP were previously described8 Affinity-purified rabbit
polyclonal anti-KSRP antibody was previously described.8 Affinity-purified
rabbit polyclonal anti-Drosha was from Abcam (Cambridge, UK). Affinity-purified
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rabbit polyclonal anti-AKT and anti-Phospho-AKT (Ser 473) were from Cell
Signaling (Danvers, MA, USA). Affinity-purified rabbit polyclonal anti-EXOSC10,
mouse monoclonal antibody anti-alpha-Tubulin, and rabbit polyclonal antibodies
anti-connexin 43 were from Sigma (St. Louis, MO, USA).
siRNA and shRNA-mediated knockdown. siRNA utilized to knock-
down Ksrp expression were described previously.8 In order to knockdown the
expression of either Akt1 or Akt2, we utilized siRNAs purchased from Santa Cruz
(Santa Cruz, CA, USA).
In vitro kinase assays. AKT2 kinase assays were performed using the
preactivated enzyme purchased from Millipore (Billerica, MA, USA) as
recommended by manufacturer. We have previously demonstrated that both
AKT1 and AKT2 phosphorylate to a similar extent recombinant KSRP.30
miRNAprofiling. MicroRNA microarray assays were provided by LC Sciences
(Houston, TX, USA). Total RNA was prepared from either control-infected (cultured
in GM or in DM) or myr-AKT2-infected (cultured in GM) C2C12 myoblasts using
Trizol (Invitrogen), enriched with RNA smaller than 40 nt using PureLink miRNA
Isolation Kit (Invitrogen) and used to interrogate a HumanMouseRat miRNA Array
(LC Sciences) comprising a total of 17 341 mature miRNA sequences, based on
Sanger miRBase release 16.0. Data were analyzed by first subtracting
the background and then normalizing the signals using a LOWESS filter
(locally-weighted regression performed at LC Sciences). The ratio of the two sets
of detected signals (log2 transformed and balanced) and P-values of the t-test were
calculated; differentially detected signals were those witho0.01 P-values.
Quantitative RT-PCR. Total RNA was isolated using the miRNeasy mini kit
(Qiagen, Milano, Italy), treated with DNAseI (Promega, Madison, WI, USA), and
retro-transcribed using miScript reverse transcription kit (Qiagen) according to
manufacturers’ instructions. For quantitative RT-PCR (qPCR), 100 ng of DNAse
I-treated total RNA were retro-transcribed and PCR reactions were performed using
the miScript SYBR green PCR kit (Qiagen) and the Realplex II Mastercycler
(Eppendorf, Milano, Italy). The sequence-specific primers used for PCR reactions
are listed in Supplementary Table S1.
Northern Blot and RNase-protection assays. Total RNA (10mg/lane)
was resolved on 15% polyacrylamide-urea gels, and electroblotted onto HyBond
Nþ membranes (GE Healthcare, Buckinghamshire, England). Membranes were
hybridized overnight with radiolabeled antisense miRNAs in ExpressHyb solution
(Clontech, Mountain View, CA, USA). After hybridization, membranes were washed
three times with 2 SSC and 0.05% SDS, twice with 0.1 SSC and 0.1% SDS,
exposed overnight to imaging screens, and analyzed using a Storm 860
PhosphorImager (GE Healthcare). The same blot was hybridized (upon stripping
in boiling 0.1% SDS) with three distinct probes, including control U6 RNA.
RNase protection assays were performed using the mirVana miRNA Probe
Contruction and mirVana miRNA Detection kits from Ambion (Austin, TX, USA)
according to manufacturers’ instructions.
Pri-miRNA in vitro processing assays. For pri-miRNA processing assays,
total cell extracts from C2C12 myoblasts were prepared in 50 mM Tris-HCl (pH 8.0),
150 mM NaCl, 0.5% Triton X-100, 1 Complete (Roche, Mannheim, Germany),
and 10% glycerol) and incubated (typically 40mg per 25ml reaction at 37 1C for the
indicated times) with in-vitro synthesized and uniformly labeled pri-miRNA (5 fmol) in
processing buffer containing 100 mM KCH3COOH, 2 mM Mg (CH3COOH)2, 10 mM
Tris-Cl (pH 7.6), 2 mM DTT, 10 mM creatine phosphate, 1 mg of creatine
phosphokinase, 1 mM ATP, 0.4 mM GTP, 0.1 mM spermine, and 2 units of Stop
RNase Inhibitor (5 PRIME, Hamburg, Germany).
RNA in vitro degradation. 32P-labeled RNAs were synthesized and used as
substrates for in vitro degradation assays as reported.8
RNA in vitro degradation assay and measure of mRNA half-life in
intact cells. 32P-labeled. RNAs were synthesized and used as substrates for
in vitro degradation assays as reported.8 AREMyog and the E3 sequence from Pitx2
30UTR were described previously.8,9
To measure the mRNA half-life, intact C2C12 myoblasts were treated with 100mM
DRB (5,6-dichloro-1-b-D-ribofuranosylbenzimidazole, 5,6-dichlorobenzimidazole
riboside), harvested at the indicated times, and total RNA was isolated and
analyzed as above.
Ribonucleoprotein complexes immunoprecipitation (RIP)
assays. RIP assays were performed as previously described in Trabucchi.27
Briefly, cell lysates were immunoprecipitated with protein A-coupled antibodies at
4 1C overnight. Pellets were sequentially washed with the following buffers: Buffer I
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, and 150 mM
NaCl); Buffer II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1,
and 500 mM NaCl); and Buffer III (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM
EDTA, 10 mM Tris-HCl, and pH 8.1). Total RNA was prepared from
immunocomplexes using Trizol (Invitrogen) retro-transcribed and amplified by
qPCR as described above. The primer sequences are detailed in Supplementary
Table S1.
Nuclear andS100 extracts preparation. Nuclear and S100 extracts were
prepared as previously described.8
GST pull-down assays. Escherichia coli, transformed with pGEX-based
recombinant plasmids (GE Healthcare) were grown until the A600 reached 0.6,
induced with 1 mM of isopropyl-b-D-thiogalactoside (IPTG) for 3 h, harvested,
washed with PBS, and lysed by sonication. After centrifugation (14 000 g for
15 min at 4 1C) the supernatants were incubated with glutathione-sepharose
beads (GE Healthcare) for 1 h at 4 1C under rotation. Beads were washed four
times with pull-down buffer (PDB, 150 mM NaCl, 20 mM Tris-HCl pH 8.0, 0.2%
Nonidet P-40, 10% glycerol, and a mixture of protein inhibitors (Complete, Roche),
saturated with bovine serum albumin, washed again with PDB, and incubated with
300mg of cell extracts (2 h, 4 1C, and rotating). Beads were collected by
centrifugation (30 s, 5000 g) and washed four times with PDB. Bound proteins
were eluted in SDS sample buffer, resolved by SDS-PAGE, and analyzed by
Immunoblot. Plasmids GST-KH1-4 and GST-KH1-4(S193) were described
previously.30
Generation of Ksrp-null mice. Generation of Ksrp-null mice (Ksrp/) is
described elsewhere.36 Briefly, a hygromycin cassette flanked by loxP sites was
designed to replace exon 1 to exon 13 of Ksrp gene and electroporated into V6.5
mouse embryonic stem (ES) cells. The cells were subsequently selected by
hygromycin (250mg/ml) and ganciclovir (2 mM). ES colonies resistant to hygromycin
and ganciclovir were genotyped by Southern blot analysis, and the Ksrp-targeted
ES clones, after Cre recombinase-mediated removal of the hygromycin cassette,
were injected into C56BL/6 blastocysts to generate chimera mice. Male chimeras
were further backcrossed with C56BL/6 females for eight generations and were then
used for the experiments. All animal studies were conducted in accordance with
guidelines for animal use and care established by the University of Alabama at
Birmingham Animal Resource Program and the Institutional Animal Care and Use
Committee.
Injury-induced muscle regeneration. Animals were anesthetized by
inhalation of Isofluorane and the site of injection was shaved and sterilized
according to the animal care requirements. 25 ml of 10mM Cardiotoxin (Latoxan,
Valence, France) (in sterile PBS) was slowly injected into the tibialis anterioris
muscle. Animals were euthanized at different time points after injection (0–14 days)
using CO2 asphyxiation, and the musculature of both lower limbs was removed and
processed for Hematoxylin–eosin staining and RNA preparation.
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